Synmosa Biopharma Corporation (TPEX:4114)
Taiwan
· Delayed Price · Currency is TWD 32.95
+0.05 (0.15%)
May 13, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Generic Drugs | 4.96B |
Log In |
Log In |
Log In |
Log In |
| Generic Drugs Growth | 17.05% |
Log In |
Log In |
Log In |
Log In |
| Active Pharmaceutical Ingredients | 179.59M |
Log In |
Log In |
Log In |
Log In |
| Active Pharmaceutical Ingredients Growth | 21.37% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Taiwan | 4.37B |
Log In |
Log In |
Log In |
Log In |
| Taiwan Growth | 12.69% |
Log In |
Log In |
Log In |
Log In |
| China | 534.01M |
Log In |
Log In |
Log In |
Log In |
| China Growth | 96.52% |
Log In |
Log In |
Log In |
Log In |
| Thailand | 54.56M |
Log In |
Log In |
Log In |
Log In |
| Thailand Growth | 37.79% |
Log In |
Log In |
Log In |
Log In |
| Singapore | 41.91M |
Log In |
Log In |
Log In |
Log In |
| Malaysia | 36.45M |
Log In |
Log In |
Log In |
Log In |
| Malaysia Growth | 18.54% |
Log In |
Log In |
Log In |
Log In |
| United States | 28.78M |
Log In |
Log In |
Log In |
Log In |
| United States Growth | -54.12% |
Log In |
Log In |
Log In |
Log In |
| Canada | 15.50M |
Log In |
Log In |
Log In |
Log In |
| Canada Growth | -55.68% |
Log In |
Log In |
Log In |
Log In |
| Other | 60.80M |
Log In |
Log In |
Log In |
Log In |
| Other Growth | -13.28% |
Log In |
Log In |
Log In |
Log In |